home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 26, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 648 active entries

W.H.P.M., Inc.

5358 North Irwindale Avenue,
Irwindale, CA 91706
United States of America, California

Phone: (626) 443-8480
Fax: (626)443-8065

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

W.H.P.M., Inc., established in 1992, is a privately held corporation headquartered at El Monte, California, only 15 minutes away from downtown Los Angeles. The Company is a pioneer in the research and development of one-step rapid membrane tests. It has been designated a registered GMP facility for in vitro diagnostic medical devices by the FDA.

W.H.P.M. is established upon over a decade of research in the bio-technological industry. Its scientific professional team has applied these years of R&D experience to their development of one-step membrane immunoassay tests. With the strong support of our sister company, WHPM Bioresearch Technology Co., Ltd., W.H.P.M. has continuously researched, developed, and produced high quality rapid test systems that have not only revolutionized the pharmaceutical industry, but have also set new industry standards and guidelines.

Our current product leader is Hemosure®, a trade name recognized worldwide in immunological fecal occult blood test (IFOBT). In year 2001, W.H.P.M. was proudly designated a sponsor in providing high quality immunological fecal occult blood tests for a large colorectal cancer-screening program; over 20,000 people in Beijing, China took part in the study. In April 2004, the Company sponsored another colorectal cancer-screening program in Hangzhou, China, in which over 60,000 people participated. Upon completion, these two recent studies together will surpass any previous clinically related studies in the world in terms of size and scope.

Through continuing clinical development, W.H.P.M. is committed to building a portfolio of quality products. Using only the highest standards, we deliver our products to the marketplace at highly competitive and affordable prices. Our mission statement clearly identifies and sets the direction for our company: "It is our goal to continually research and develop novel tests systems to enhance the quality of life."



Selected Categories:
Product Company   Service Company
Biopharma
- General
Biotech
- General
Diagnostics
- General
Pharmaceutical
- General
Supplier
- Equipment
Contract
- Research
Laboratory
- Analytical

Last update of this entry: September 21, 2011

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.